North America Apheresis Equipment Market to Widen at USD 2 Bn by 2026

Published Date: 2020-03-31

Request a sample

According to the Graphical Research new growth forecast report titled “North America Apheresis Equipment Market Value By Product, Application, Procedure, Technology, Industry Analysis Report, Regional Outlook”, Estimated To Exceed USD 2.0 Billion By 2026. Apheresis refers to the method of blood processing that is used in the treatment of diverse clinical conditions. The apheresis equipment separates blood into white blood cells, red blood cells, platelets, and plasma components and returns the remaining non-targeted plasma or platelets. Increasing prevalence of blood diseases have imposed various measures to ensure quality of blood and its products. With rising incidence of blood disorders in North America, the demand for apheresis equipment is estimated to expand in the forthcoming timeline.

According to the Center for Disease Control & Prevention (CDC), around 100,000 individuals were estimated to be affected with sickle cell anemia in the U.S. Apheresis machines are beneficial during the treatment of a variety of neoplastic, hematologic, and neurologic disorders. These devices have several applications for the in-situ separation of blood components, including automated RBC exchange in adults or children with sickle cell disease.

Technological advancement such as automated apheresis equipment will drive the market growth in the region. The next generation apheresis machines reduce human intervention with automated interface systems, graphical user interface displays, and screen navigation. This help in providing more efficient and faster results. For instance, Fresenius Kabi introduced the efficient COM.TEC C5 separation chamber that can reduce the separation time to less than 60 minutes. Furthermore, new protocols are developed to ensure effective treatment protocol manner, that will further impact apheresis equipment market growth in the foreseeable future.

However, risks and complications associated with apheresis devices may hamper the industry growth in the forthcoming years.

Based on product, the industry is segmented as disposable apheresis kits and apheresis machines. Apheresis machines segment held considerable market share in 2019 and is estimated to experience over 10.5% CAGR over the analysis timeframe. Apheresis machines receive blood removed from donor’s body and separate it into its several components. These machines are widely used during transfusion process. Furthermore, presence of technologically advanced machines help in separating the blood components, thereby augmenting the segment growth.

On the basis of application, the market is classified as renal disease, neurology, hematology and others. Renal disease was valued at over USD 140.0 million in 2019. Increasing usage of apheresis equipment in renal treatment will escalate the demand for apheresis equipment in North America. According to the National Institute of Diabetes and Digestive and Kidney Diseases, prevalence of chronic kidney disease in general population is around 14%. Approximately 661,000 Americans suffer from kidney failure, of which 468,000 patients are on dialysis. Thus, the increasing prevalence of chronic kidney diseases will fuel the market growth in the forecast period.

On the basis of procedure, the industry is segmented as photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis and others. Photopheresis segment accounted for over 22.0% share in 2019. Photopheresis is an extracorporeal technique of separating white blood cells (WBCs) from the blood. After separation from blood, the WBCs are treated with photosensitizing agents and sent back to the blood stream in this procedure. Growing number of organ transplantations and rising cases of organ rejection will thus lead to significant demand for photopheresis. Moreover, wide range of applicability of apheresis equipment will further contribute to photopheresis market growth.

Based on technology, the market comprises of membrane filtration and centrifugation. Centrifugation segment was valued at around USD 480.5 million in 2019. Efficient fractioning of plasma proteins from the whole blood aid in driving the customer preference for the technology. Centrifugation separation is the technique for segregation of blood components based on their specific gravity, by usage of centrifugation bowl or belt.

During centrifugation, blood is drawn from the patient and is immediately mixed with the anticoagulant and this anti-coagulated blood is pumped into the centrifugation bowl for the processing. The desired components are harvested and returned to the patient using apheresis equipment. Centrifugation technology is highly adopted in the North America owing to its capacity to provide cellular therapies, thus aiding in driving the segmental size.

Canada apheresis equipment market is estimated to witness more than 10.5% CAGR during the forthcoming years. Rising prevalence of chronic kidney diseases (CKD) in the country contributes to considerable market growth. According to the Kidney International Reports, the prevalence of CKD in Canada is estimated to be 71.9 per 1,000 individuals and around 4 million people have CKD. Additionally, growing number of transfusion services will augment Canada apheresis equipment market growth in the upcoming years.

Major market players in the North America apheresis equipment market are Fresenius SE & Co. KGaA, Cerus Corporation, B. Braun Melsungen AG, Haemonetics Corporation among others. These market players are undertaking strategies such as collaborations, acquisitions and product innovation to drive their competitiveness. For instance, in January 2017, Hemacare Corporation entered into strategic alliance with a subsidiary of One Blood Inc, Florida. The alliance helped the company to develop more products related to apheresis thereby enhancing its product base.

North America apheresis equipment market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:

North America Apheresis Equipment Market Share, By Application, 2015-2026 (USD Million)

  • Renal disease
  • Neurology
  • Hematology
  • Others

North America Apheresis Equipment Market Size, By Product, 2015-2026 (USD Million)

  • Disposable Apheresis Kits
  • Apheresis Machines

North America Apheresis Equipment Market Value, By Procedure, 2015-2026 (USD Million)

  • Photopheresis
  • Plasmapheresis
  • LDL apheresis
  • Plateletpheresis
  • Leukapheresis
  • Erythrocytapheresis
  • Others

North America Apheresis Equipment Market Trends, By Technology, 2015-2026 (USD Million)

  • Membrane Filtration
  • Centrifugation

The above information is provided for the following region and countries:

  • North America
    • U.S.
    • Canada